Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

Mild cognitive impairment (MCI) is a nosological entity proposed as an intermediate state between normal aging and dementia. MCI seems to represent an early stage of Alzheimer's disease (AD) and there is a great interest in the relationship between MCI and the progression to AD. Some studies have demonstrated an accumulation of products of free radical damage in the central nervous system and in the peripheral tissues of subjects with AD or mild cognitive impairment. The aim of the present work was to evaluate the serum levels of some enzymatic antioxidant defences like superoxide dismutase (SOD) and glutathione peroxidase (GPX), as well as lipid peroxidation markers like MDA (malondialdehyde), in MCI and AD patients, compared with age-matched healthy controls. The subjects of this study (45 patients) consisted of 15 individuals with mild cognitive impairment (MCI), 15 with Alzheimer's disease (AD) and 15 healthy age-matched controls. Biochemical analyses showed a similar decrease of the main enzymatic antioxidant defences (SOD and GPX) and increased production of lipid peroxidation marker (MDA) in the serum of the MCI and AD patients, compared to age-matched control group. This study clearly demonstrates that oxidative stress damage occurs in patients with MCI and AD. Moreover, some enzymatic markers of oxidative stress are similar in MCI and AD patients, suggesting that oxidative damage could be one important aspect for the onset of AD.

[1]  D. Knopman,et al.  Alternative Medicine and Alzheimer Disease , 2008, The neurologist.

[2]  N. Cairns,et al.  Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer’s disease brain , 2004, Journal of Neural Transmission.

[3]  K. Davis,et al.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.

[4]  W. Markesbery,et al.  Oxidative damage in mild cognitive impairment and early Alzheimer's disease , 2007, Journal of neuroscience research.

[5]  B. Christophersen.  Formation of monohydroxy-polyenic fatty acids from lipid peroxides by a glutathione peroxidase. , 1968, Biochimica et biophysica acta.

[6]  Y. Awasthi,et al.  Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. , 2004, Antioxidants & redox signaling.

[7]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[8]  I. Santana,et al.  Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[9]  A. Jordão,et al.  Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. , 2007, Investigative ophthalmology & visual science.

[10]  D. Butterfield,et al.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease , 2007, Brain Research.

[11]  D. Petersen,et al.  α,β-Unsaturated Aldehydes Increase GlutathioneS-Transferase mRNA and Protein: Correlation with Activation of the Antioxidant Response Element , 1998 .

[12]  I. Santana,et al.  Decreased superoxide dismutase activity in erythrocytes from patients with Alzheimer's disease , 1993 .

[13]  M. Philpot,et al.  Concepts of mild memory impairment in the elderly and their relationship to dementia—a review , 1992 .

[14]  M. Beal.  Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment , 2005, Neurobiology of Aging.

[15]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[16]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[17]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[18]  Patrizia Mecocci,et al.  Mild cognitive impairment: a systematic review. , 2007, Journal of Alzheimer's disease : JAD.

[19]  P. Gil,et al.  Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment , 2008, Free radical research.

[20]  C. Scavone,et al.  Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease , 2005, Neurobiology of Aging.

[21]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[22]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[23]  D. Aslan,et al.  Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. , 2007, Clinical biochemistry.

[24]  Kehkashan Parveen,et al.  Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type , 2009, Brain Research.

[25]  F. Panza,et al.  Circulating biomarkers of cognitive decline and dementia. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[26]  E. Lima,et al.  Vitamin A and lipid peroxidation in patients with different forms of leprosy. , 2007, Revista do Instituto de Medicina Tropical de Sao Paulo.

[27]  D. Fuchs,et al.  Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease , 2008, Free radical research.

[28]  I. Bourdel-Marchasson,et al.  Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. , 2001, Age and ageing.

[29]  J. Trojanowski,et al.  Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. , 2002, Archives of neurology.

[30]  C. Maier,et al.  Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[31]  F. Schmitt,et al.  Evidence of increased oxidative damage in subjects with mild cognitive impairment , 2005, Neurology.

[32]  P. Mecocci,et al.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  C. Maier,et al.  Book Review: Role of Superoxide Dismutases in Oxidative Damage and Neurodegenerative Disorders , 2002 .

[34]  C. Berr,et al.  Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidase. , 1996, Free radical biology & medicine.

[35]  I. Appollonio,et al.  Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. , 2004, Current Alzheimer research.

[36]  D. Butterfield,et al.  Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment , 2006, Neuroscience Letters.

[37]  P. Mecocci,et al.  Antioxidants for the treatment of mild cognitive impairment , 2004, Neurological research.

[38]  P. Mecocci,et al.  Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment , 2009, Ageing Research Reviews.

[39]  Lewis H Kuller,et al.  Ginkgo biloba for prevention of dementia: a randomized controlled trial. , 2008, JAMA.

[40]  D. Butterfield,et al.  Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment , 2008, Neurochemical Research.

[41]  Rana Noor,et al.  Superoxide dismutase--applications and relevance to human diseases. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[42]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.